Skip to content

The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle in Hypercapnic COPD Patients

The Effect of Non-invasive Ventilation on the Oxygenation of Peripheral Muscle Tissue, Cardiovascular System and Exercise Capacity in Hypercapnic COPD Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02877290
Enrollment
20
Registered
2016-08-24
Start date
2016-08-31
Completion date
2017-10-31
Last updated
2017-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Hypercapnia

Keywords

COPD, NIRS, NIV, Exercise

Brief summary

In this study, 20 hypercapnic COPD patients will perform two constant workrate endurance cycle tests. One test will be while using non-invasive Ventilation (NIV) support, one without in a randomized cross-over design. The aim is to measure, whether NIV is able to change peripheral and respiratory muscle oxygenation.

Detailed description

In this study patients will perform one incremental work rate test to obtain peak work rate. On the following days two constant work rate cycle endurance tests (CWRT) will be performed at 60% of Peak work rate using a randomised cross-over design. Between the two CWRTs there will be one hour of recovery time in between. One of the CWRTs will be performed with the support of non-invasive Ventilation (NIV), the other one without. Respiratory and cardiovascular parameters will be observed through transcutaneous measurement of CO2 (Sentec device) and near-infrared spectroscopy devices. The purpose of this study is, to examine whether the use of NIV not only decreases patients dyspnoea, but also has positive effects on the patients cardiovascular System, exercise capacity and muscle oxygenation. The investigators will examine the tissue oxygen saturation in the 7th intercostal space (reflecting a respiratory muscle) and on the M. vastus lateralis of the leg during both CWRTs. With the Support of NIV, it is expected to see a change in the oxygenation towards a better perfusion of the leg muscle, due to a facilitation of the work of breathing. This may result in a later onset of leg fatigue and an increased exercise capacity of the patients. To have an equivalent workload all parameters will be compared during isotime. To conclude, aim of this study is to record the interplay of Oxygenation and Perfusion between the Intercostal muscles and the peripheral leg muscle during exercise. The investigators hypothesize, that the use of NIV may change the oxygenation in favour of the leg muscle through relieving the respiratory muscles.

Interventions

Sponsors

ResMed
CollaboratorINDUSTRY
Schön Klinik Berchtesgadener Land
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Chronic obstructive pulmonary disease GOLD (Global initiative for chronic obstructive lung disease) stage IV * Hypercapnia: pCO2\>50mmHg (at rest or in exercise) * written consent

Exclusion criteria

* orthopaedic comorbidities that do not allow a cycle endurance test * acute exacerbation of COPD * Cardiac insufficiency, acute coronary syndrome

Design outcomes

Primary

MeasureTime frameDescription
cycle endurance timemaximum 20 minutestime patient ist able to cycle at 60% of his peak work rate

Secondary

MeasureTime frameDescription
Borg scale of leg fatigue30 minutesIn the beginning and in the end of the constant work rate tests patients will be asked to rate their current Level of leg fatigue on the modified Borg scale from 0 to 10
Oxygen saturation30 minutesMeasurement of the oxygen saturation during the constant work rate tests
Heart rate30 minutesMeasurement of the heart rate during the constant work rate tests using a pulse oximeter
Borg scale of dyspnoea30 minutesIn the beginning and in the end of the constant work rate tests patients will be asked to rate their current level of dyspnoea on the modified Borg scale from 0 to 10
arterial carbondioxide partial pressure30 minutesrecording of the transcutaneously measured arterial carbondioxide partial pressure using Sentec technology during the constant work rate tests
Tissue Saturation Index30 minutesthe near infrared technology delivers the Tissue Saturation Index throughout the constant work rate test
total hemoglobin30 minutesthe near infrared technology delivers the Tissue Saturation Index throughout the constant work rate test
Arterial blood pressure30 minutesRiva-Rocci measurement of the arterial blood pressure before and in the end of the constant work rate tests

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026